RILEY SCHEELER: Open Payments
NPI 1730948761 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $177 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Kerendia, GARDASIL 9, PREVNAR 20, BREZTRI, ELIQUIS, Auvelity.
Industry payments across MD — which companies pay providers there.
